Kexing Biopharm Obtained IND Approval for Its Self-developed GB05 from U.S. FDA
SHENZHEN, China, Feb. 14, 2025…
SHENZHEN, China, Feb. 14, 2025…
CULVER CITY, Calif., Feb. 14, …
HONG KONG, Feb. 14, 2025 /PRNe…
XI’AN, China, Feb. 14, 2…
DUBAI, UAE, Feb. 14, 2025 /PRN…
LambdaTest Partner Awards 2024…
Envision Energy secured contra…
New customers enjoy 3.0%* p.a.…
SHENZHEN, China, Feb. 14, 2025…